Corporate Action-Board approves Dividend
Annual General Meeting of the Company is scheduled to be held on August 13, 2018.25-05-2018
25-05-2018
Corporate Action-Board approves Dividend
The Board of Directors at their meeting held today have recommended final dividend of Rs. 3.50/- (350%) per equity share of Re. 1/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 13, 2018.25-05-2018
Book Closure For Annual General Meeting And Payment Of Dividend.
Book Closure for Annual General Meeting and payment of dividend.25-05-2018
Book Closure For Annual General Meeting And Payment Of Dividend
Book Closure for Annual General Meeting and payment of dividend25-05-2018
Board Meeting-Outcome of Board Meeting
Audited Financial Results along with Audit Report of the Statutory Auditors for the quarter / year ended on March 31, 2018.25-05-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Dutasteride and Tamsulosin Hydrochloride Capsules25-05-2018
Board Meeting On May 24, 2018.
Further to our earlier intimation dated May 4, 2018 regarding board meeting, the Board of Directors [the Board] shall also consider the following proposals: (i) to raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR, subject to approval of the shareholders,...21-05-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Further to the earlier communication today on the captioned subject, please consider the date as May 25, 2018, which was inadvertently mentioned as May 28, 2018.16-05-2018